MW
Publicaties op Oncologisch.com
Verbetering van anti-CTLA-4-therapieën door peptidemaskering en Fc-niet-fucosylering
Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma.
Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy.
Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised, doub...
Carfilzomib verbetert de progressievrije overleving significant bij hoogrisico multipel myeloom